ACT 2 Logo
TREATMENT · ENCLOMIPHENE · DIAGNOSTIC

Primary vs Secondary Low Testosterone: Why It Decides the Treatment

"Low testosterone" is a result, not a diagnosis. Two men with the identical number can have opposite problems: one whose testes have failed, and one whose testes are fine but are not being told to work. The treatments for those two men are different, and one of them cannot be helped by enclomiphene at all.

The low testosterone page covers how the number is measured. This page covers what to do with the two numbers next to it.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.
Medically reviewed by Johnathan Chance Miller, M.D. September 7, 2026

The system, briefly

The hypothalamus signals the pituitary. The pituitary releases LH and FSH into the blood. LH tells the testes to make testosterone; FSH tells them to make sperm. Testosterone feeds back on the hypothalamus and pituitary and moderates the signal. It is a thermostat, and like a thermostat it can fail at the sensor, at the furnace, or in the wiring between.

Primary hypogonadism is furnace failure. The testes cannot produce enough testosterone however hard they are driven. The pituitary, detecting the shortfall, shouts — LH and FSH are high. Causes include genetic conditions like Klinefelter's, prior chemotherapy or radiation, testicular injury or infection, and, commonly, age itself when it acts directly on the testes.

Secondary hypogonadism is a signal failure. The testes are capable, but the pituitary is not asking. LH and FSH are low or inappropriately normal — normal-looking numbers that are wrong for a testosterone that low. Causes include obesity and metabolic disease, which suppress the signal through estrogen and inflammation; obstructive sleep apnea; opioid and some other medications; high prolactin; pituitary problems; severe illness; and, again, age, when it acts on the brain rather than the testes.

Mixed pictures are common after 45. The testes are a bit weaker and the signal is a bit weaker. That is its own conversation.

Why the distinction decides the treatment

Enclomiphene works by turning up the signal. It removes estrogen's brake on the pituitary and lets LH and FSH rise. If the testes can respond — secondary hypogonadism — testosterone rises with them, and sperm production is preserved. This is the population enclomiphene was developed for and tested in.

If the testes cannot respond — primary hypogonadism — turning up a signal that is already at maximum does nothing. LH is already high; making it higher produces no more testosterone. For that man, the only way to restore testosterone is to supply it: replacement, with its own trade-offs, discussed on the men's TRT page.

So the first question is not "which drug?" It is "which kind?" — and two numbers on a panel answer it.

What the numbers look like

We draw total and free testosterone, LH, FSH, estradiol, prolactin and SHBG, on a morning sample, and repeat a low testosterone before acting on it — the Endocrine Society's standard, because a single low value is wrong often enough to matter.

Then the pattern:

Low testosterone with high LH and FSH — primary. Enclomiphene is not the answer.

Low testosterone with low or normal LH and FSH — secondary. Enclomiphene is a candidate, provided the cause of the signal failure has been looked for.

That last clause matters. Secondary hypogonadism is a finding that sometimes has a cause worth finding. A high prolactin, a very low testosterone with a very low LH, or symptoms like headache or visual change point to the pituitary itself and need imaging before any treatment. Untreated sleep apnea suppresses the signal and is treatable on its own — see sleep that does not restore you. Obesity suppresses it, and weight loss can restore it without any hormone at all — see tirzepatide and testosterone. A medication list is read for opioids and other suppressants.

The point of typing the result is not only to choose a drug. It is to notice when the right treatment is not a drug for testosterone.

Where the SHBG number fits

A man with a normal total testosterone and a high SHBG can have a low free testosterone — the fraction that actually acts — and symptoms to match. Our page on what SHBG means covers it. It is one of the commonest reasons a man is told his testosterone is "normal" when it is not doing its job, and it is why the free value is on our panel.

Questions

Frequently asked questions

  • Primary: the testes cannot make enough testosterone, and LH/FSH are high. Secondary: the testes could, but the pituitary is not signaling, and LH/FSH are low or inappropriately normal.

  • Secondary. It works by raising the pituitary signal, which only helps if the testes can respond. It does nothing in primary hypogonadism.

  • LH and FSH on the same panel as testosterone, on a repeated morning sample. High LH/FSH points to the testes; low or normal points to the signal.

  • Sometimes. Weight loss, treating sleep apnea and stopping a suppressing medication can each restore the signal. Those are looked for before anything is prescribed.

  • When LH and testosterone are both very low, when prolactin is high, or when there are symptoms — headache, visual change — that point to the pituitary. That is a referral, not something we manage.

  • Often a high SHBG, which leaves less free testosterone to act. The free value and SHBG are on our panel for that reason.

Your next step

Where this fits in your plan

Start with a baseline panel that includes LH, FSH and free testosterone, not testosterone alone. The Enclomiphene ODT page covers the product; the low testosterone page covers the condition.

We measure first. Then we act.

References

  1. Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism 2018;103:1715–1744.
  2. Mulhall JP et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. Journal of Urology 2018;200:423–432.
  3. Wu FCW et al. Identification of late-onset hypogonadism in middle-aged and elderly men (EMAS). Journal of Clinical Endocrinology & Metabolism 2008;93:2737–2745.
  4. Corona G et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. European Journal of Endocrinology 2013;168:829–843.
  5. Earl JA, Kim ED. Enclomiphene citrate for the treatment of secondary male hypogonadism. Expert Opinion on Pharmacotherapy 2019;20:1747–1754.

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.

Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

We measure first. Then we act.

Start with a baseline. Then decide about enclomiphene / dhea / boron / pregnenolone odt.